Immutep LtdASX: IMM

Immutep Corporate Presentation

· Issued by Immutep Ltd via ASX

Filed with ASX ·

1 Unlocking the power of the immune system to fight cancer and autoimmune disease Immutep Corporate Presentation August 2026 (ASX:IMM, NASDAQ:IMMP) 2 Forward Looking Statements The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889...

View Attachment

6ix hasn’t read this filing yet.

Immutep Ltd on 6ix

In the deck

Earlier from Immutep

Later from Immutep

All Immutep news releases